AGN Media thread, page-109

AGN has a big future for sure and why I’m invested and see significant upside over next 12-18 months for AGN moving from a 110 million market cap and towards a billion dollar market cap

The only thing I question on AGN coming from a pharmaceutical background is that peptides need to always be stored at 4 degrees. Dry peptides can be stored at room temp for about a month but again AGN is not a dry peptide. They are never ever rarely made in a tablet form or any other formulation like nasal sprays due to the drug being unstable. So what I question is that it limits the availability and there will be huge difficulty getting it to access multiple sports, army officers and high risk industries that are prone to traumatic brain injury. For the drug to only be given by infusion creates a lot of difficulty. But that’s my only concern and will create a lot of limitations, cost is another but there is nothing on the market at the moment for this treatment so it’s fine to be charging 7000-10000 dollars a dose

NYR is a 6 million market cap about to clear its safety tests. NYR only needs to be proven it’s safe. AGN has done all the heavy lifting that inhibiting calcium intake in the brain works. So yes NYR the only drug in the world that can be made in tablet form, nasal sprays and injectables that treats both TB and stroke has a significant short term and long term rise on safety clearance. It’s why the US Army is behind the drug because of its phase 1 clearance for both TB and stroke but also it’s formulations that it’s available in and drug molecules cost pennies compared to peptides which are extremely expensive